KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Supernus Pharmaceuticals (SUPN) Short-Term Debt issuances (2023)

Historic Short-Term Debt issuances for Supernus Pharmaceuticals (SUPN) over the last 1 years, with Q1 2023 value amounting to $93.0 million.

  • Supernus Pharmaceuticals' Short-Term Debt issuances changed N/A to $93.0 million in Q1 2023 from the same period last year, while for Dec 2023 it was $93.0 million, marking a year-over-year change of. This contributed to the annual value of $93.0 million for FY2023, which is N/A changed from last year.
  • According to the latest figures from Q1 2023, Supernus Pharmaceuticals' Short-Term Debt issuances is $93.0 million.
  • Supernus Pharmaceuticals' 5-year Short-Term Debt issuances high stood at $93.0 million for Q1 2023, and its period low was $93.0 million during Q1 2023.